Welcome, Guest. Please login or register.
September 20, 2021, 11:03:53 am

Login with username, password and session length


Members
Stats
  • Total Posts: 55057
  • Total Topics: 4836
  • Online Today: 45
  • Online Ever: 1314
  • (June 22, 2016, 05:23:42 am)
Users Online
Users: 0
Guests: 32
Total: 32

Welcome

Welcome to the Hep Forums, a round-the-clock discussion area for people who have Hepatitis B, C or a co-infection, their friends and family and others with questions about hepatitis and liver health. Check in frequently to read what others have to say, post your comments, and hopefully learn more about how you can reach your own health goals.

Privacy Warning: Please realize that these forums are open to all, and are fully searchable via Google and other search engines. If this concerns you, then do not use a username or avatar that are self-identifying in any way. We do not allow the deletion of anything you post in these forums, so think before you post.
  • The information shared in these forums, by moderators and members, is designed to complement, not replace, the relationship between an individual and his/her own physician.
  • All members of these forums are, by default, not considered to be licensed medical providers. If otherwise, users must clearly define themselves as such.
  • Product advertisement (including links); banners; and clinical trial, study or survey participation—is strictly prohibited by forums members unless permission has been secured from the Hep Forum Moderators.
Finished Reading This? You can collapse this or any other box on this page by clicking the symbol in each box.

Author Topic: Truvada as PrEP for HIV Also Greatly Lowers the Risk of Hepatitis B  (Read 1570 times)

0 Members and 1 Guest are viewing this topic.

Offline Hep Editors

  • Member
  • Posts: 784
    • Hep Mag
Taking Truvada (tenofovir disoproxil fumarate/emtricitabine) as pre-exposure prophylaxis (PrEP) against HIV can also prevent acquisition of hepatitis B virus (HBV), according to a recent study of men who have sex with men (MSM) in Japan, aidsmap reports.

Daisuke Mizushima, MD, of the National Center for Global Health and Medicine in Tokyo, presented findings from the retrospective cohort study of records regarding 591 MSM at the 2020 Conference on Retroviruses and Opportunistic Infections in Boston earlier this month.

None of the men had had hep B previously or were living with HIV. One hundred forty-eight (25%) of the men took PrEP for at least part of the January 2018 to September 2019 follow-up period.

For more...
https://www.hepmag.com/article/truvada-prep-hiv-also-greatly-lowers-risk-hepatitis-b

 


© 2021 Smart + Strong. All Rights Reserved.   terms of use and your privacy
Smart + Strong® is a registered trademark of CDM Publishing, LLC.